Monday, April 13, 2026

πŸ“„ First Phase of Abstract Submission Closing Soon

The first phase of abstract submission for the Global Vaccines Innovation and Immunology Conference (GVX 2026) is closing soon. Researchers, scientists, healthcare professionals, and industry experts are invited to submit their work and contribute to advancing vaccine science.

Abstract submissions provide an opportunity to showcase innovative research, share scientific insights, and engage with a global network of experts in vaccinology and immunology.


🧬 Why Submit Your Abstract?

Submitting your abstract allows you to:

• Present your research at an international conference
• Gain recognition among global experts
• Contribute to scientific discussions in vaccine innovation
• Be part of conference proceedings with DOI publication (
vaccines.miconferences.com)

Accepted abstracts may be selected for oral or poster presentations, providing valuable exposure and networking opportunities.


πŸ“Š Important Deadline

The first phase of abstract submission is closing soon, so early submission is highly recommended to secure your participation. (vaccines.miconferences.com)


🌐 Conference Details

πŸ“… September 21–23, 2026
πŸ“ London, United Kingdom & Online

πŸ“„ Submit Your Abstract
https://vaccines.miconferences.com/abstract-submission

πŸ”— Event Website
https://vaccines.miconferences.com/

#GVX2026 #AbstractSubmission #Vaccines #Immunology #VaccineResearch #BiomedicalResearch #GlobalHealth #MedicalConference #HealthcareInnovation

No comments:

Post a Comment

πŸŽ₯ Explore Highlights from Our Previous Conferences

Mathews International Conferences is dedicated to creating global platforms that connect researchers, academicians, healthcare professionals...